Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery
Guanming Shao,Yonghui Ma,Chao Qu,Ruiqian Gao,Chengzhan Zhu,Linlin Qu,Kui Liu,Na Li,Peng Sun,Jingyu Cao
DOI: https://doi.org/10.2147/jhc.s455612
2024-04-04
Journal of Hepatocellular Carcinoma
Abstract:Guanming Shao, &ast Yonghui Ma, &ast Chao Qu, Ruiqian Gao, Chengzhan Zhu, Linlin Qu, Kui Liu, Na Li, Peng Sun, Jingyu Cao Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Peng Sun; Jingyu Cao, Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266000, People's Republic of China, Email ; Background: Circulating eosinophils are associated with tumor development. An eosinophil-related index, the neutrophil to eosinophil ratio (NER), can be used to predict the prognosis of patients with tumors. However, there is still a lack of efficient prognostic biomarkers for HCC. In this study, we aimed to investigate the predictive value of the NER and develop an optimal machine learning model for the recurrence of HCC patients. Patients and methods: A retrospective collection of 562 patients who underwent hepatectomy with a pathologic diagnosis of HCC was performed. The relationship between NER and progression-free survival (PFS) was investigated. We developed a new machine learning framework with 10 machine learning algorithms and their 101 combinations to select the best model for predicting recurrence after hepatectomy. The performance of the model was assessed by the area under the curve (AUC) of characteristics and calibration curves, and clinical utility was evaluated by decision curve analysis (DCA). Results: Kaplan‒Meier curves showed that the PFS in the low NER group was significantly better than that in the high NER group. Multivariate Cox regression analysis showed that NER was an independent risk factor for recurrence after surgery. The random survival forests (RSF) model was selected as the best model that had good predictive efficacy and outperformed the TNM, BCLC, and CNLC staging systems. Conclusion: The NER has good predictive value for postoperative recurrence in patients with hepatocellular carcinoma. Machine learning model based on NER can be used for accurate predictions. Keywords: hepatocellular carcinoma, liver resection, recurrence, machine learning, neutrophil-to-eosinophil ratio Primary liver cancer is the sixth most common cancer and the third most common cause of cancer-related deaths worldwide. 1,2 Hepatocellular carcinoma (HCC) accounts for 75–85% of primary liver cancers. 1 Currently, hepatectomy is still considered one of the most effective therapeutic approaches for the treatment of primary liver cancer. 3 However, due to the high recurrence rate of HCC, the long-term prognosis of patients with HCC after hepatectomy remains poor, with a 5-year recurrence rate of 60–70%. 4 Although HCC-related biomarkers and prognostic models have been initially applied in clinical practice, the results are still unsatisfactory. Therefore, the question of how to screen more valuable indicators and construct models is the focus of clinical research. Many studies have shown that chronic inflammation plays a major role in cancer cell proliferation, angiogenesis, and immunosuppression, and cancer-related inflammation (CRI) is associated with cancer prognosis. 5 Serological indicators such as neutrophil counts and lymphocyte counts have been used for biomarker development in clinical studies because of their advantages in convenience and low cost. 6 Several inflammatory markers have been shown to predict the prognosis of patients with HCC, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), 7 and lymphocyte-to-monocyte ratio (LMR). 8 However, their predictive ability for the prognosis of HCC patients after hepatectomy remains controversial. The eosinophil count has been increasingly used in tumor prognostic studies as a newly developed inflammatory marker. 9 A retrospective study of HCC patients treated with sorafenib found that lower peripheral blood eosinophil counts were associated with a poorer prognosis. 10 A lower eosinophil-to-neutrophil ratio (NER) was found to be associated with a better prognosis in a study of patients with metastatic renal cell carcinoma treated with natalizumab plus ibritumomab. 11 Nevertheless, there is still a lack of studies correlating NER with HCC prognosis. Favorable results have been reported from studies applying machine learning models to HCC. It has been demonstrated that machine learning models outperform traditional regression models in predicting HCC development. 12 In this study, we aimed to analyze the relationship between preoperative NER and recurrence after hepatectomy in pa -Abstract Truncated-
oncology